News

Upsher-Smith Laboratories, LLC  declared that it sought U.S Food and Drug Administration's approval for new drug application (ANDA) for Bumetanide Tablets, USP, 0.5 mg, 1 mg, and 2 mg,…
Read More...

Industry leader in orthopaedic devices using advanced functional materials, MedShape declared successful performance of first surgeries using DynaNail XL TTC Fusion System.  The…
Read More...

Mallinckrodt plc affirmed enrolling first patient in the company's Phase 4, multi center, randomized, double-blind, placebo-controlled pilot study to facilitate evaluation of the…
Read More...

U.S  Food and Drug Administration conceded to Multi  Radiance Medical's MR4 Laser technology for neck and shoulder pain relief under the Product Classification NHN. MR4 Laser technology…
Read More...

Takeda Pharmaceutical company Limited asserted that the U.S Food and Drug Administration has extended Fast Track designation to TAK-426 i.e Takeda's Zika virus vaccine candidate. …
Read More...

European Organisation for Research and Treatment of Cancer (EORTC) and Foundation Medicine collaborate to ascertain eligibility of patients for oncology clinical Trials of  Foundation…
Read More...

In a bid to commercialize NERLYNX, Puma Biotechnology and Medison Pharma have forayed into an exclusive licensing agreement in Israel as it is currently not approved for…
Read More...

U.S Patent and Trademark Office permits a patent titled  “Method for Inducing an Immune Response and Formulations Thereof” for CEL-SCI Corporation's LEAPS Vaccine Platform technology.…
Read More...

Agilent Technologies ventured into a partnership with Science Exchange to met out Agilent-enabled services to the research community worldwide. Carolina Livi, Ph.D., academic segment…
Read More...

International contract research organization (CRO), Synteract paved way for a new Chief Commercial Officer on board, Jack Shannon. Jack Shannon joins Synteract from Chiltern where he…
Read More...

Sanofi and Ablynx engaged in the discovery and development of Nanobodies forayed into an agreement under which Sanofi will extend acquisition of all of the outstanding ordinary shares,…
Read More...

U.S. Food and Drug Administration (FDA) has approved BioCardia's Investigational Device Exemption for the CardiAMP Chronic Myocardial Ischemia (CMI) Trial to treat patients with…
Read More...

U.S FDA has sanctioned CutisPharma's FIRVANQ (vancomycin hydrochloride) for oral solution, for the treatment of Clostridium difficile associated diarrhea and enterocolitis caused by …
Read More...

Theravance Biopharma and Mylan N.V confirmed U.S Food and Drug Administration's acceptance for reviewing the company's New Drug Application (NDA) for revefenacin (TD-4208), an…
Read More...

electroCore sought 510(k) clearance from the U.S Food and Drug Administration for an extended label for gammaCore (nVNS) as an acute treatment of pain associated with migraine in adult…
Read More...

Dragonfly Therapeutics welcomes on board Dr. Jean-Marie Cuillerot, MD as its Chief Medical Officer. Dr. Cuillerot set to spearhead clinical development of Dragonfly's natural Killer…
Read More...

Harris Healthcare asserts that Emerald Health Information Systems will transition from MediSolution, Harris Healthcare's sister company under the Harris umbrella, to Harris Healthcare…
Read More...

Supplier of quality compounding products, supplies and equipment, Letco Medical along with ARL Bio Pharma collaborate to roll out their joint Quality Savings Program. The program…
Read More...

Global company engaged in the design, assembly and distribution of advanced therapeutic solutions for the minimally invasive treatment of vascular disease, QT Vascular successfully…
Read More...

Wuxi Biologics and Aravive Biologics collaborate to extend their biologics manufacturing collaboration, based on the rapid success achieved in the process development, scale-up and cGMP…
Read More...